Compile Data Set for Download or QSAR
Report error Found 10 Enz. Inhib. hit(s) with all data for entry = 50004187
Target3-oxoacyl-[acyl-carrier-protein] synthase 2(Staphylococcus aureus)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50479865(Platensimycin)
Affinity DataIC50: 1.13E+3nMAssay Description:Inhibition of FabF-mediated type 2 fatty acid synthesis in Staphylococcus aureus by cell free assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2020
Entry Details Article
PubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 2(Staphylococcus aureus)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50479871(Dihydroplatensimycin)
Affinity DataIC50: 4.50E+3nMAssay Description:Inhibition of FabF-mediated type 2 fatty acid synthesis in Staphylococcus aureus by cell free assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2020
Entry Details Article
PubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 2(Staphylococcus aureus)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50479873(CHEMBL492363)
Affinity DataIC50: 5.26E+3nMAssay Description:Inhibition of FabF-mediated type 2 fatty acid synthesis in Staphylococcus aureus by cell free assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2020
Entry Details Article
PubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 2(Staphylococcus aureus)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50479866(Phenyl Dihydroplatensimycin)
Affinity DataIC50: 7.69E+3nMAssay Description:Inhibition of FabF-mediated type 2 fatty acid synthesis in Staphylococcus aureus by cell free assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2020
Entry Details Article
PubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 2(Staphylococcus aureus)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50479867(CHEMBL521849)
Affinity DataIC50: 2.08E+4nMAssay Description:Inhibition of FabF-mediated type 2 fatty acid synthesis in Staphylococcus aureus by cell free assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2020
Entry Details Article
PubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 2(Staphylococcus aureus)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50479872(CHEMBL494403)
Affinity DataIC50: 2.34E+4nMAssay Description:Inhibition of FabF-mediated type 2 fatty acid synthesis in Staphylococcus aureus by cell free assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2020
Entry Details Article
PubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 2(Staphylococcus aureus)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50479868(CHEMBL523838)
Affinity DataIC50: 2.84E+4nMAssay Description:Inhibition of FabF-mediated type 2 fatty acid synthesis in Staphylococcus aureus by cell free assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2020
Entry Details Article
PubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 2(Staphylococcus aureus)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50479870(CHEMBL494959)
Affinity DataIC50: 1.55E+5nMAssay Description:Inhibition of FabF-mediated type 2 fatty acid synthesis in Staphylococcus aureus by cell free assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2020
Entry Details Article
PubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 2(Staphylococcus aureus)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50479869(CHEMBL523161)
Affinity DataIC50: 1.66E+5nMAssay Description:Inhibition of FabF-mediated type 2 fatty acid synthesis in Staphylococcus aureus by cell free assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2020
Entry Details Article
PubMed
Target3-oxoacyl-[acyl-carrier-protein] synthase 2(Staphylococcus aureus)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50479874(CHEMBL492364)
Affinity DataIC50: 4.36E+5nMAssay Description:Inhibition of FabF-mediated type 2 fatty acid synthesis in Staphylococcus aureus by cell free assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2020
Entry Details Article
PubMed